Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Kulkarni PS, Padmapriyadarsini C, Vekemans J, Bavdekar A, Gupta M, Kulkarni P, Garg BS, Gogtay NJ, Tambe M, Lalwani S, Singh K, Munshi R, Meshram S, Selvavinayagam TS, Pandey K, Bhimarasetty DM, Ramakrishnan SR, Bhamare C, Dharmadhikari A, Budhawant C, Bonhomme CJ, Thakar M, Kurle SN, Kelly EJ, Gautam M, Gupta N, Panda S, Bhargava B, Poonawalla CS, Shaligram U, Kapse D, Gunale B. Kulkarni PS, et al. Among authors: ramakrishnan sr. Hum Vaccin Immunother. 2024 Dec 31;20(1):2304974. doi: 10.1080/21645515.2024.2304974. Epub 2024 Mar 21. Hum Vaccin Immunother. 2024. PMID: 38512394 Free PMC article. Clinical Trial.
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.
Kulkarni PS, Padmapriyadarsini C, Vekemans J, Bavdekar A, Gupta M, Kulkarni P, Garg BS, Gogtay NJ, Tambe M, Lalwani S, Singh K, Munshi R, Meshram S, Selvavinayagam TS, Pandey K, Bhimarasetty DM, Ramakrishnan SR, Bhamare C, Dharmadhikari A, Vadakkedath R, Bonhomme CJ, Thakar M, Kurle SN, Kelly EJ, Gautam M, Gupta N, Panda S, Bhargava B, Shaligram U, Kapse D, Gunale B; COVISHIELD Study Group. Kulkarni PS, et al. Among authors: ramakrishnan sr. EClinicalMedicine. 2021 Dec;42:101218. doi: 10.1016/j.eclinm.2021.101218. Epub 2021 Nov 30. EClinicalMedicine. 2021. PMID: 34870133 Free PMC article.
COVID-19 and heart disease in children: What have we learned?
Kadiyani L, Ramakrishnan S. Kadiyani L, et al. Ann Pediatr Cardiol. 2023 Mar-Apr;16(2):81-86. doi: 10.4103/apc.apc_104_23. Epub 2023 Aug 16. Ann Pediatr Cardiol. 2023. PMID: 37767179 Free PMC article. No abstract available.
Pediatric cardiology: In search for evidence.
Yadav S, Ramakrishnan S. Yadav S, et al. Ann Pediatr Cardiol. 2023 Sep-Oct;16(5):311-315. doi: 10.4103/apc.apc_47_24. Epub 2024 Apr 1. Ann Pediatr Cardiol. 2023. PMID: 38766456 Free PMC article. No abstract available.
Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.
Gupta K, Ramakrishnan S, Zachariah G, Rao JS, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Jain V, Gupta P, Gupta R, Bansal S, Nath RK, Tyagi S, Wander GS, Gupta S, Mandal S, Senguttuvan NB, Subramanyam G, Roy D, Datta S, Ganguly K, Routray SN, Mishra SS, Singh BP, Bharti BB, Das MK, Deb PK, Deedwania P, Seth A; CSI-Great India BP Campaign Investigators. Gupta K, et al. Int J Cardiol Hypertens. 2020 Oct 7;7:100055. doi: 10.1016/j.ijchy.2020.100055. eCollection 2020 Dec. Int J Cardiol Hypertens. 2020. PMID: 33465185 Free PMC article.
Mass protruding out from pulmonary vein to left atrium.
Shaheer Ahmed A, Arava SK, Ramakrishnan S. Shaheer Ahmed A, et al. Postgrad Med J. 2020 May;96(1135):300. doi: 10.1136/postgradmedj-2019-137176. Epub 2019 Nov 15. Postgrad Med J. 2020. PMID: 31732512 No abstract available.
35 results